332
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Processing challenges with solid dosage formulations containing vitamin E TPGS

, , , , &
Pages 296-304 | Received 05 Jun 2012, Accepted 26 Sep 2012, Published online: 09 Nov 2012

References

  • Jens-Uwe AHJ, Rainer HM. Nanocrystal technology, drug delivery and clinical applications. Int J Nanomedicine 2008;3:295–310.
  • Mohanachandran PS, Sindhumol PG, Kiran TS. Enhancement of solubility and dissolution rate: an overview. Pharmacie Globale (IJCP) 2010;4:1–10.
  • Hetal T, Bindesh P, Sneha T. A review on techniques for oral bioavailability of drugs. Int Pharm Sc Rev Res 2010;4:203–223.
  • Bajaj H, Bisht S, Yadav M, Singh V. Bioavailability enhancement: a review. Int J Pharma Bio Sc 2011;2:202–216.
  • Vemula VR, Lagishetty V, Lingala S. Solubility enhancement techniques. Int J Pharm Sc Review Res 2010;5:41–51.
  • Singh MC, Sayyad AB, Sawant SD. Review on various techniques of solubility enhancement of poorly soluble drugs with special emphasis on solid dispersion. J Pharm Res 2010;3: 2494–2501.
  • Sokol RJ, Johnson KE, Karrer FM, Narkewicz MR, Smith D, Kam I. Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E. Lancet 1991;338:212–214.
  • Dintaman JM, Silverman JA. Inhibition of P-glycoprotein by D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 1999;16:1550–1556.
  • Chang T, Benet LZ, Hebert MF. The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers. Clin Pharmacol Ther 1996;59:297–303.
  • Wacher VJ, Wong S, Wong HT. Peppermint oil enhances cyclosporine oral bioavailability in rats: comparison with D-α-tocopheryl poly(ethylene glycol 1000) succinate (TPGS) and ketoconazole. J Pharm Sci 2002;91:77–90.
  • Hong-Wei Wu S, Hopkins WK. Characteristics of D-α-tocopheryl PEG 1000 succinate for applications as an absorption enhancer in drug delivery systems. Pharm Technol 1999:1–10.
  • Danjo K, Kamiya K, Otsuka A. Effect of temperature on the sticking of low-melting point materials. Chem Pharm Bull 1993;41:1423–1427.
  • Jin F, Tatavarti A. Tabletability assessment of conventional formulations containing Vitamin E tocopheryl polyethylene glycol succinate. Int J Pharm 2010;389:58–65.
  • Wu SH, Clipse NM, Yuan J. Application of vitamin E TPGS 1000 NF as a melt binder for making tablets. AAPS Pharm Sci 2003;5:AAPS Abstract 1053.
  • Yuan J, Clipse NM, Wu SH. Tablets comprising a poorly compressible active agent and tocopherol polyethyleneglycol succinate (TPGS). 2006. WO 2006/047067 A1.
  • Pandey P, Tao J, Chaudhury A, Ramachandran R, Gao GZ, Bindra DS. A combined experimental and modeling approach to study the effects of high-shear wet granulation process parameters on granule characteristics. Pharm Dev Technol 2012, early online, doi:10.3109/10837450.2012.700933.
  • Wikberg M, Alderborn G. Compression characteristics of granulated materials IV. The effect of granule porosity on the fragmentation propensity and the compactability of some granulations. Int J Pharm 1991;69:239–253.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.